EYE 0.00% 25.0¢ nova eye medical limited

@elpassiveI think it is quite likely we could see this. Not only...

  1. 15,147 Posts.
    lightbulb Created with Sketch. 3756
    @elpassive

    I think it is quite likely we could see this. Not only would the price have to double with revenue to maintain the same valuation multiple, but we would likely see a jump from the very small valuation currently being applied (EV around 2x revenue), to a much higher multiple more suitable for a growth stock (8-10x). So that would be 2x for the sales growth alone, and then another 4-5x increase on top of that to get this to a more appropriate valuation multiple. If they announce profitability at the same time, which is quite likely given that they are predicting cash flow positive by FY25, that would likely give the share price an extra bump in addition to all of that as well. That's what happens when you have a stock valued at only $50m, the rerates can happen very quick and can be very large. As it increases in size the rerate only speeds up, as larger investors gain access to it and quickly join other investors in taking positions.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
0.000(0.00%)
Mkt cap ! $57.20M
Open High Low Value Volume
25.0¢ 25.0¢ 25.0¢ $22.78K 91.15K

Buyers (Bids)

No. Vol. Price($)
5 81958 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 50000 1
View Market Depth
Last trade - 15.39pm 29/05/2024 (20 minute delay) ?
Last
25.0¢
  Change
0.000 ( 3.85 %)
Open High Low Volume
25.0¢ 25.5¢ 24.5¢ 143797
Last updated 15.39pm 29/05/2024 ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.